1. Home
  2. MRNA vs BSAC Comparison

MRNA vs BSAC Comparison

Compare MRNA & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • BSAC
  • Stock Information
  • Founded
  • MRNA 2010
  • BSAC 1977
  • Country
  • MRNA United States
  • BSAC Chile
  • Employees
  • MRNA 5800
  • BSAC N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • BSAC Commercial Banks
  • Sector
  • MRNA Health Care
  • BSAC Finance
  • Exchange
  • MRNA Nasdaq
  • BSAC Nasdaq
  • Market Cap
  • MRNA 9.2B
  • BSAC 13.4B
  • IPO Year
  • MRNA 2018
  • BSAC 1994
  • Fundamental
  • Price
  • MRNA $23.73
  • BSAC $29.40
  • Analyst Decision
  • MRNA Hold
  • BSAC Hold
  • Analyst Count
  • MRNA 15
  • BSAC 3
  • Target Price
  • MRNA $37.15
  • BSAC $25.00
  • AVG Volume (30 Days)
  • MRNA 11.9M
  • BSAC 281.6K
  • Earning Date
  • MRNA 11-06-2025
  • BSAC 10-30-2025
  • Dividend Yield
  • MRNA N/A
  • BSAC 3.38%
  • EPS Growth
  • MRNA N/A
  • BSAC 42.15
  • EPS
  • MRNA N/A
  • BSAC 0.01
  • Revenue
  • MRNA $2,232,000,000.00
  • BSAC $2,434,135,287.00
  • Revenue This Year
  • MRNA N/A
  • BSAC $41.14
  • Revenue Next Year
  • MRNA $10.38
  • BSAC $5.30
  • P/E Ratio
  • MRNA N/A
  • BSAC $12.11
  • Revenue Growth
  • MRNA N/A
  • BSAC 20.98
  • 52 Week Low
  • MRNA $23.15
  • BSAC $18.19
  • 52 Week High
  • MRNA $56.70
  • BSAC $30.18
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 40.92
  • BSAC 71.95
  • Support Level
  • MRNA $23.48
  • BSAC $28.27
  • Resistance Level
  • MRNA $25.56
  • BSAC $30.18
  • Average True Range (ATR)
  • MRNA 1.42
  • BSAC 0.58
  • MACD
  • MRNA -0.36
  • BSAC 0.03
  • Stochastic Oscillator
  • MRNA 4.30
  • BSAC 68.09

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.

Share on Social Networks: